These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 9556058)

  • 61. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
    Mo H; Elson CE
    Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid.
    McKenna CE; Kashemirov BA; Błazewska KM; Mallard-Favier I; Stewart CA; Rojas J; Lundy MW; Ebetino FH; Baron RA; Dunford JE; Kirsten ML; Seabra MC; Bala JL; Marma MS; Rogers MJ; Coxon FP
    J Med Chem; 2010 May; 53(9):3454-64. PubMed ID: 20394422
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.
    Mönkkönen H; Auriola S; Lehenkari P; Kellinsalmi M; Hassinen IE; Vepsäläinen J; Mönkkönen J
    Br J Pharmacol; 2006 Feb; 147(4):437-45. PubMed ID: 16402039
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel statin-mediated "prenylation block-and-release" assay provides insight into the membrane targeting mechanisms of small GTPases.
    Ali BR; Nouvel I; Leung KF; Hume AN; Seabra MC
    Biochem Biophys Res Commun; 2010 Jun; 397(1):34-41. PubMed ID: 20471365
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
    Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ
    Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism.
    Rogers MJ; Chilton KM; Coxon FP; Lawry J; Smith MO; Suri S; Russell RG
    J Bone Miner Res; 1996 Oct; 11(10):1482-91. PubMed ID: 8889848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis.
    Matsumoto T; Nagase Y; Iwasawa M; Yasui T; Masuda H; Kadono Y; Nakamura K; Tanaka S
    Arthritis Rheum; 2011 Dec; 63(12):3908-17. PubMed ID: 21898348
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.
    Karlic H; Thaler R; Gerner C; Grunt T; Proestling K; Haider F; Varga F
    Cancer Genet; 2015 May; 208(5):241-52. PubMed ID: 25978957
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth.
    Mönkkönen H; Kuokkanen J; Holen I; Evans A; Lefley DV; Jauhiainen M; Auriola S; Mönkkönen J
    Anticancer Drugs; 2008 Apr; 19(4):391-9. PubMed ID: 18454049
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P; Nguyen H; Barbier A; Baron R
    J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
    [TBL] [Abstract][Full Text] [Related]  

  • 75. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Mühlbauer RC; Bauss F; Schenk R; Janner M; Bosies E; Strein K; Fleisch H
    J Bone Miner Res; 1991 Sep; 6(9):1003-11. PubMed ID: 1838661
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition.
    Nagaoka Y; Kajiya H; Ozeki S; Ikebe T; Okabe K
    J Dent Res; 2015 Apr; 94(4):594-601. PubMed ID: 25535203
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
    Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P
    Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
    Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
    J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts.
    Takami M; Suda K; Sahara T; Itoh K; Nagai K; Sasaki T; Udagawa N; Takahashi N
    Bone; 2003 Apr; 32(4):341-9. PubMed ID: 12689676
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bisphosphonate mechanism of action.
    Reszka AA; Rodan GA
    Curr Rheumatol Rep; 2003 Feb; 5(1):65-74. PubMed ID: 12590887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.